Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products

Products

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC3783 Nsc-670224
Toxitant of Saccharomyces_cerevisiae>Saccharomyces cerevisiae
More description
DCC3782 Nsc663627
IκBα phosphorylation inhibitor
More description
DCC3781 Nsc66098
Novel potent inhibitor of Huntington's disease (HD) pathogenesis via targeting CAG repeats RNA and Poly Q protein
More description
DCC3780 Nsc65847
Novel dual inhibitor of viral and Streptococcus pneumoniae neuraminidase
More description
DCC3779 Nsc-657186
Novel selective non-zinc-binding MMP-2 inhibitor
More description
DCC3778 Nsc636795
Novel inhibitor of ABCG2 transporter function
More description
DCC3777 Nsc-627757
Novel DNA repair inhibitor
More description
DCC3776 Nsc61610
Novel activator of lanthionine synthetase C-like 2 (LANCL2), down-modulating pulmonary inflammation through the downregulation of TNF-α and MCP-1 and reduction in the infiltration of neutrophils, accelerating recovery and inducing IL-10-mediated regulator
More description
DCC3775 Nsc-60339
Novel efflux pump inhibitor (EPI)
More description
DCC3774 Nsc57971
Novel non-peptide disruptor of IKKß/NEMO complex
More description
DCC3773 Nsc-57774
Novel potent SHP2 Inhibitor with Anti-Proliferative Activity in Breast Cancer Cell Lines
More description
DCC3772 Nsc-57148
Novel antagonist of the Grb7 SH2 domain; Antitumor Agent
More description
DCC3771 Nsc56452
Novel specific inhibitor of EGF receptor autophosphorylation and cell proliferation in HeLa cells by disrupting allosteric activation of EGF-stimulated dimer
More description
DCC3770 Nsc-55158
Novel antagonist of the Grb7 SH2 domain; Antitumor Agent
More description
DCC3769 Nsc52101
Novel potent inhibitor of Huntington's disease (HD) pathogenesis via targeting CAG repeats RNA and Poly Q protein
More description
DCC3768 nsc48693 Dihydrochloride
Potent apoptosis inducer in pancreatic cancer cells
More description
DCC3767 Nsc-4231
Novel Rho-Kinase-II Inhibitor with Vasodilatory Activity
More description
DCC3766 Nsc-347518
DT-diaphorase inhibitor
More description
DCC3765 Nsc339614 Potassium Salt
Selective potentiator at GluN1/GluN2C and GluN1/GluN2D receptors
More description
DCC3764 Nsc-339579
Novel potent Mycobacterium tuberculosis DHFR inhibitor
More description
DCC3763 Nsc-33353
Potent inhibitor of the AcrAB-TolC efflux pump in Escherichia coli, potentiating the antibacterial activities of novobiocin and erythromycin upon binding to the membrane fusion protein AcrA
More description
DCC3762 Nsc-311068
Novel selective inhibitor of TET1 transcription and 5-hydroxymethylcytosine (5hmC) modification, effectively inhibiting cell viability in AML with high expression of TET1
More description
DCC3761 Nsc30049
Novel inhibitor of Chk1 pathway in 5-FU-resistant CRC bulk and stem cell populations
More description
DCC3760 Nsc-299202
Novel potent gonist of Human G Protein-Coupled Receptor-35 (hGPR35) (EC50 8 nM)
More description
DCC3759 Nsc-2888
Novel Rho-Kinase-II Inhibitor with Vasodilatory Activity
More description
DCC3758 Nsc-279287
Novel Inhibitor of the p53-mdm2 Interaction, Activating p53-Dependent Transcription in mdm2-Overexpressing Cells
More description
DCC3757 Nsc265473
Novel substrate of ABCG2
More description
DCC3756 nsc-252359
Specific Ligand for Stem Loop 3 Ribonucleic Acid of the Packaging Signal Ψ of Human Immunodeficiency Virus-1
More description
DCC3755 Nsc-2488 [5459-61-0]
Novel Rho-Kinase-II Inhibitor with Vasodilatory Activity
More description
DCC3754 Nsc24674
Novel 3C-like protease inhibitor of SARS-CoV-2
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X